Atherosclerosis is a complex and progressive cardiovascular condition that involves the gradual buildup of plaque in the arteries, restricting blood flow and potentially leading to serious health complications. This condition stems from the accumulation of cholesterol, fats, and inflammatory cells on the inner walls of arteries, forming atherosclerotic plaques. As these plaques grow, they can narrow the arteries, impeding the smooth flow of blood to vital organs and tissues. Atherosclerosis is a significant contributor to various cardiovascular diseases, including heart attacks, strokes, and peripheral artery disease. Risk factors for developing atherosclerosis include high cholesterol levels, hypertension, smoking, diabetes, and a sedentary lifestyle. Understanding the underlying mechanisms of atherosclerosis is crucial for developing effective prevention and treatment strategies. Lifestyle modifications, such as adopting a heart-healthy diet, regular exercise, and managing risk factors, play a pivotal role in mitigating the progression of atherosclerosis and promoting overall cardiovascular health. Ongoing research continues to unravel the intricacies of atherosclerosis, paving the way for innovative therapies and interventions aimed at reducing its impact on global health
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India